NO20004998L - Fettsyrederivater av gallesyrer og gallesyrederivater - Google Patents

Fettsyrederivater av gallesyrer og gallesyrederivater

Info

Publication number
NO20004998L
NO20004998L NO20004998A NO20004998A NO20004998L NO 20004998 L NO20004998 L NO 20004998L NO 20004998 A NO20004998 A NO 20004998A NO 20004998 A NO20004998 A NO 20004998A NO 20004998 L NO20004998 L NO 20004998L
Authority
NO
Norway
Prior art keywords
bile
acid derivatives
acid
fatty acid
bile salt
Prior art date
Application number
NO20004998A
Other languages
English (en)
Other versions
NO316875B1 (no
NO20004998D0 (no
Inventor
Tuvia Gilat
Original Assignee
Galmed Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galmed Int Ltd filed Critical Galmed Int Ltd
Publication of NO20004998D0 publication Critical patent/NO20004998D0/no
Publication of NO20004998L publication Critical patent/NO20004998L/no
Publication of NO316875B1 publication Critical patent/NO316875B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
NO20004998A 1998-04-08 2000-10-04 Fettsyrederivater av gallesyrer og gallesyrederivater NO316875B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12399898A IL123998A (en) 1998-04-08 1998-04-08 Conjugates of bile salts and pharmaceutical preparations containing them
PCT/IL1999/000173 WO1999052932A1 (en) 1998-04-08 1999-03-25 Fatty acid derivatives of bile acids and bile acid derivatives

Publications (3)

Publication Number Publication Date
NO20004998D0 NO20004998D0 (no) 2000-10-04
NO20004998L true NO20004998L (no) 2000-12-06
NO316875B1 NO316875B1 (no) 2004-06-07

Family

ID=11071405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004998A NO316875B1 (no) 1998-04-08 2000-10-04 Fettsyrederivater av gallesyrer og gallesyrederivater

Country Status (25)

Country Link
US (3) US6395722B1 (no)
EP (1) EP1071702B1 (no)
JP (1) JP5031942B2 (no)
KR (1) KR100615560B1 (no)
CN (1) CN100386339C (no)
AT (1) ATE222923T1 (no)
AU (1) AU742944B2 (no)
BR (1) BRPI9909908B8 (no)
CA (1) CA2325933C (no)
CZ (1) CZ300824B6 (no)
DE (1) DE69902647T2 (no)
DK (1) DK1071702T3 (no)
EA (1) EA003392B1 (no)
ES (1) ES2183526T3 (no)
HU (1) HU229513B1 (no)
ID (1) ID26042A (no)
IL (1) IL123998A (no)
NO (1) NO316875B1 (no)
NZ (1) NZ507309A (no)
PL (1) PL199271B1 (no)
PT (1) PT1071702E (no)
SI (1) SI1071702T1 (no)
TR (1) TR200002876T2 (no)
UA (1) UA70318C2 (no)
WO (1) WO1999052932A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US8975246B2 (en) 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
US20080026077A1 (en) * 2002-11-12 2008-01-31 John Hilfinger Methods and compositions of gene delivery agents for systemic and local therapy
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
US8304383B2 (en) * 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
WO2007084549A2 (en) * 2006-01-20 2007-07-26 Filiberto Zadini Drug-eluting stent with atherosclerotic plaques dissolving pharmacological preparation
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20090305943A1 (en) * 2006-07-18 2009-12-10 Sven Siegel Cyclodextrin blends with crystal growth inhibitors
US8877917B2 (en) 2007-04-23 2014-11-04 Alnylam Pharmaceuticals, Inc. Glycoconjugates of RNA interference agents
US20080287429A1 (en) * 2007-05-15 2008-11-20 Z & Z Medical Holdings, Inc. Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
US20100311708A1 (en) * 2007-07-25 2010-12-09 Tarek Moustafa Use of nor-bile acids in the treatment of arteriosclerosis
CN101367859B (zh) * 2007-08-17 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸胆汁酸偶合物及其医药用途
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
WO2009082606A2 (en) 2007-12-04 2009-07-02 Alnylam Pharmaceuticals, Inc. Folate conjugates
US20090247608A1 (en) 2007-12-04 2009-10-01 Alnylam Pharmaceuticals, Inc. Targeting Lipids
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives
JP5788312B2 (ja) 2008-04-11 2015-09-30 アルニラム ファーマスーティカルズ インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 標的リガンドをエンドソーム分解性成分と組み合わせることによる核酸の部位特異的送達
EP2367839A4 (en) 2008-11-03 2012-07-04 Univ Tufts METHODS AND COMPOSITIONS FOR PREVENTING GERMINATION AND EXCROIDANCE OF C. DIFFICILE SPORES
WO2010086864A1 (en) * 2009-02-02 2010-08-05 Galmed International Ltd. Methods and compositions for treating alzheimer's disease
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
ES2746311T3 (es) * 2011-06-16 2020-03-05 Allergan Sales Llc Composiciones que contienen ácido desoxicólico y agua desionizada al 10 % en etanol, dirigidas a la purificación del ácido desoxicólico
CA2920457A1 (en) * 2013-08-08 2015-02-12 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
HUE045209T2 (hu) * 2013-12-04 2019-12-30 Galmed Res & Development Ltd Aramchol-sók
US11571431B2 (en) 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
JP2017519726A (ja) * 2014-06-01 2017-07-20 ガルメッド リサーチ アンド ディベロップメント リミテッド． リポジストロフィー治療用脂肪酸胆汁酸複合体
JOP20200092A1 (ar) 2014-11-10 2017-06-16 Alnylam Pharmaceuticals Inc تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
US10849911B2 (en) 2015-06-10 2020-12-01 Galmed Research And Development Ltd. Low dose compositions of Aramachol salts
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
CN106496300B (zh) * 2016-10-19 2018-05-18 上海博志研新药物技术有限公司 花生胆酸及其中间体的制备方法
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
WO2018087600A1 (en) * 2016-11-10 2018-05-17 Galmed Research And Development Ltd. Inhibition of fibrosis in non-alcoholic fatty liver disease patients
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
WO2018223836A1 (zh) * 2017-06-07 2018-12-13 苏州科睿思制药有限公司 一种脂肪酸胆汁酸偶合物的晶型及其制备方法和用途
SG11202100715WA (en) 2018-08-13 2021-02-25 Alnylam Pharmaceuticals Inc HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
IT202000000328A1 (it) 2020-01-10 2021-07-10 Ice S P A Metodo di preparazione dell'aramchol
CN114524857B (zh) * 2022-02-22 2023-06-30 中国科学院微生物研究所 胆酸衍生物及其应用
CN116687850A (zh) 2022-02-24 2023-09-05 甘莱制药有限公司 包含环状膦酸酯化合物的药物组合物及其制备方法与用途
WO2023227723A1 (en) * 2022-05-26 2023-11-30 Pharmazell Gmbh An improved process for the preparation of aramchol and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856953A (en) * 1973-05-15 1974-12-24 Intellectual Property Dev Corp Method of treating fatty liver
IT1167479B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido chenodesossicolico
IT1167478B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido ursodesossicolico
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
DE19824123A1 (de) * 1998-05-29 1999-12-02 Hoechst Marion Roussel De Gmbh Gallensäurederivat, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
BR9909908B1 (pt) 2014-03-18
HUP0101653A2 (hu) 2001-12-28
CA2325933C (en) 2008-06-10
TR200002876T2 (tr) 2000-12-21
WO1999052932A1 (en) 1999-10-21
US6384024B1 (en) 2002-05-07
NO316875B1 (no) 2004-06-07
ATE222923T1 (de) 2002-09-15
NZ507309A (en) 2003-06-30
EA200000888A1 (ru) 2001-04-23
US6589946B2 (en) 2003-07-08
BRPI9909908B8 (pt) 2021-05-25
PL343360A1 (en) 2001-08-13
PT1071702E (pt) 2003-01-31
HUP0101653A3 (en) 2002-02-28
CZ300824B6 (cs) 2009-08-19
AU742944B2 (en) 2002-01-17
EA003392B1 (ru) 2003-04-24
PL199271B1 (pl) 2008-09-30
JP5031942B2 (ja) 2012-09-26
BR9909908A (pt) 2000-12-26
DK1071702T3 (da) 2002-12-30
KR20010042342A (ko) 2001-05-25
CA2325933A1 (en) 1999-10-21
ID26042A (id) 2000-11-16
HU229513B1 (en) 2014-01-28
CN1296492A (zh) 2001-05-23
EP1071702B1 (en) 2002-08-28
JP2002511482A (ja) 2002-04-16
KR100615560B1 (ko) 2006-08-25
SI1071702T1 (en) 2003-04-30
DE69902647T2 (de) 2003-04-24
CZ20003625A3 (cs) 2001-01-17
US6395722B1 (en) 2002-05-28
ES2183526T3 (es) 2003-03-16
NO20004998D0 (no) 2000-10-04
US20020091111A1 (en) 2002-07-11
CN100386339C (zh) 2008-05-07
IL123998A (en) 2004-09-27
AU3051599A (en) 1999-11-01
DE69902647D1 (de) 2002-10-02
EP1071702A1 (en) 2001-01-31
UA70318C2 (uk) 2004-10-15

Similar Documents

Publication Publication Date Title
NO20004998L (no) Fettsyrederivater av gallesyrer og gallesyrederivater
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
JO2503B1 (en) Benzathiazole derivatives
WO2003022210A3 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
CA2260777A1 (en) Pentafluorobenzenesulfonamides and analogs
NO940789D0 (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
CA2370244A1 (en) Piperidine derivatives
MXPA03009553A (es) Uso de acido biliar o conjugados de acidos grasos de sales biliares.
ATE389655T1 (de) Pyrimidinderivate
NO307447B1 (no) Anvendelse av et pregnanderivat
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
HUP0301257A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és topoizomeráz I és II inhibitorokat tartalmazó kombinált tumorellenes kompozíciók
MX9707046A (es) Composiciones que comprenden nicotinilalanina y un inhibidor de conjugacion de glicina o vitamina b6.
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
HUP0301234A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és alkilezőszereket tartalmazó kombinált tumorellenes kompozíciók
WO2001030804A3 (en) Salt form of a conjugate useful in the treatment of prostate cancer
AP9400608A0 (en) "New nicotinic acid derivative".
ATE254460T1 (de) Anhydrovinblastin zur behandlung von krebs
CA2215319A1 (en) Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GALMED RESEARCH AND DEVELOPMENT LTD, IL

MK1K Patent expired